| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 4,791 | 4,931 | 4,784 | 5,912 | | Cost of Revenue | 3,250 | 3,004 | 3,185 | 3,101 | | | Gross Profit | 1,541 | 1,927 | 1,599 | 2,811 | | | Operating Expenses | | Research Development | 526 | 543 | 618 | 748 | | Selling General and Administrative | 1,373 | 1,615 | 1,673 | 1,674 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (358) | (231) | (692) | 389 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| 7 | 11 | 22 | | Earnings Before Interest And Taxes | (352) | (224) | (681) | 411 | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (352) | (224) | (681) | 411 | | Income Tax Expense | 1 | 34 | 47 | 10 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (353) | (258) | (728) | 401 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (353) | (258) | (728) | 401 | | Preferred Stock And Other Adjustments | (73) | (73) | (73) | (79) | | | Net Income Applicable To Common Shares | ($426) | ($331) | ($801) | $322 |
|
0.51% Nasdaq 
Income Statement
